Heart Transplant Companies
The process of heart transplantation involves collaboration among various entities in the medical field, including hospitals, pharmaceutical companies, and organ procurement organizations.
Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Latest Heart Transplant Companies Updates:
United Therapeutics acquires Organogenics Inc.: This move strengthens United Therapeutics' portfolio in xenotransplantation, aiming to develop xenotransplant organs like pig hearts for human heart transplantation, potentially alleviating the organ shortage crisis.
Toshiba Medical Systems partners with GE Healthcare to improve transplant workflow: This collaboration focuses on integrating Toshiba's surgical imaging technologies with GE Healthcare's data management solutions, streamlining processes and enhancing surgical precision.
TransMedics Organ Care System receives FDA approval for extended heart preservation: This technology allows hearts to be kept viable outside the body for longer, potentially increasing the pool of suitable donor organs and saving more lives.
Abbott receives CE Mark approval for its ReliantHeart assist device for destination therapy: This minimally invasive device offers long-term support for patients awaiting heart transplants, improving their quality of life while waiting for suitable donors.
List of Heart Transplant Key companies in the market:
- Apaxis Medical, Inc.
- CardiacAssist Inc.
- SynCardia Systems, LLC
- Optum Inc.
- CARMAT
- HeartWare International Inc.
- Thoratec Corporation
- Calon Cardio
Heart Transplant Market Highlights:
Heart Transplant Market Highlights:
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
